Clinical Trials Sponsored by MIV Therapeutics Inc
Total 3071 results
-
Ottawa Hospital Research InstituteRespironics, California, Inc.; Therapeutic Monitoring SystemsCompletedCritical IllnessCanada
-
Elysium Therapeutics, Inc.National Institute on Drug Abuse (NIDA); Medpace, Inc.; Ohio Third Frontier; Charles...RecruitingAcute PainUnited States
-
Modulation Therapeutics, Inc.H. Lee Moffitt Cancer Center and Research InstituteRecruitingUveal Melanoma | MetastaticUnited States
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIA; Juno Therapeutics, Inc.Not yet recruiting
-
Barbara Parker, MDOncternal Therapeutics, IncCompletedBreast NeoplasmsUnited States
-
Alice MimsKaryopharm Therapeutics IncCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Kari KendraKaryopharm Therapeutics IncCompletedRecurrent MelanomaUnited States
-
Insight Therapeutics, LLCBrown University; Genentech, Inc.; Case Western Reserve UniversityActive, not recruitingInfluenza | Influenza, Human | Influenza -Like IllnessUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
University of North Carolina, Chapel HillMidmark Corporation; Monitored Therapeutics, IncCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia | LeukemiaUnited States
-
Imperial College LondonSarepta Therapeutics, Inc.; Department of Health, United KingdomCompletedDuchenne Muscular DystrophyUnited Kingdom
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterTerminatedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous LineageUnited States
-
Michael Vogelbaum, MD, PhDInfuseon Therapeutics, Inc.Withdrawn
-
Wake Forest UniversityEKR Therapeutics, IncTerminatedHip ArthroplastyUnited States
-
Michael Vogelbaum, MD, PhDInfuseon Therapeutics, Inc.CompletedMalignant Glioma | WHO Grade III or IV Recurrent GliomaUnited States
-
Erin BertinoKaryopharm Therapeutics IncWithdrawnRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, IncTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Pancreatic Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage... and other conditionsUnited States
-
Edward Lain, MDVyne Therapeutics Inc.CompletedAcne VulgarisUnited States
-
Hartford HospitalNational Institute of Mental Health (NIMH); Oui Therapeutics, Inc.CompletedSuicidal Ideation | Suicide, AttemptedUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncTerminatedHepatocellular CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
SPR Therapeutics, Inc.United States Department of Defense; NDI Medical, LLCCompletedPhantom Limb Pain | Residual Limb Pain | Post-Amputation PainUnited States
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Bhavana BhatnagarKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
Erin BertinoKaryopharm Therapeutics IncTerminatedRecurrent Small Cell Lung CarcinomaUnited States
-
VistaGen Therapeutics, Inc.National Institute on Drug Abuse (NIDA); Cato ResearchCompletedNeuropathic PainUnited States
-
Brian Jerkins, MDOcular Therapeutix, Inc.Not yet recruitingGlaucoma Following SurgeryUnited States
-
The New York Eye Surgery CenterOcular Therapeutix, Inc.TerminatedGlaucoma | CataractUnited States
-
Cathleen McCabe MDOcular Therapeutix, Inc.Terminated
-
Jina Pharmaceuticals Inc.Lambda Therapeutic Research Ltd.; Intas Pharmaceuticals, Ltd.RecruitingTriple Negative Breast CancerUnited States, India
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Myelogenous LeukemiaUnited States, Canada, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumRecruitingLymphoma, B-Cell | Hodgkin Lymphoma | Lymphoblastic Lymphoma | Lymphoma, T-Cell | AML | Hematologic Malignancy | MDS | Acute Undifferentiated Leukemia | ALL | Mixed Phenotype Acute Leukemia | BPDCNUnited States, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedRelapsed Acute Lymphoblastic Leukemia | Allergy to PEG e.Coli Asparaginase | Allergy to Native e.Coli AsparaginaseUnited States
-
Mast Therapeutics, Inc.Worldwide Clinical Trials; Synteract, Inc.; Thywill Latam Solutions SRL; OCASA...CompletedA Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.Breast Cancer | Non-small Cell Lung Cancer | Non-Hodgkins LymphomaArgentina
-
University of Wisconsin, MadisonBristol-Myers Squibb; Madison Vaccines Inc. (MVI); AIQ SolutionsActive, not recruitingProstate CancerUnited States
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)RecruitingCMML | AML With Monocytic DifferentiationUnited States
-
Advancing Clinical Therapeutics Globally for HIV...National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting
-
Advancing Clinical Therapeutics Globally for HIV...National Institute of Allergy and Infectious Diseases (NIAID)RecruitingHIV-1-infectionMalawi, Botswana, South Africa
-
Massachusetts General HospitalAlkermes, Inc.; Otsuka America Pharmaceutical; Eisai Inc.; Janssen Pharmaceuticals and other collaboratorsRecruitingDepression | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Use of Atypical Antipsychotics During PregnancyUnited States
-
Ottawa Hospital Research InstituteOntario Institute for Cancer Research; Intensity Therapeutics, Inc.Recruiting
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Candel Therapeutics, Inc.RecruitingGlioma | Glioblastoma | Astrocytoma | Malignant Glioma of Brain | Brain Cancer | Brain Tumor | Glioblastoma Multiforme | Ependymoma | Ganglioglioma | Oligodendroglioma | Malignant Astrocytoma | Anaplastic Oligodendroglioma of Brain (Diagnosis) | Mixed Oligo-Astrocytoma | Pylocytic/Pylomyxoid AstrocytomaUnited States
-
Ki Health Partners. LLCRevance Therapeutics, Inc.; The Los Angeles Headache CenterActive, not recruitingMigraine DisordersUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Affini-T Therapeutics, Inc.Active, not recruiting